Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Head and Neck Neoplasms × Sorafenib × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 49 Carcinoma, Renal Cell 23 Liver Neoplasms 22 Neoplasms 18 Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 14 Kidney Neoplasms 10 Leukemia, Myeloid, Acute 9 Melanoma 8 Sarcoma 7 Prostatic Neoplasms 7 Neoplasm Metastasis 6 Lung Neoplasms 6 Glioblastoma 6 Ovarian Neoplasms 5 Brain Neoplasms 5 Thyroid Neoplasms 4 Recurrence 4 Pancreatic Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leiomyosarcoma 3 Gliosarcoma 3 Gallbladder Neoplasms 3 Carcinoma 3

Interventions

Cisplatin 60 Cetuximab 51 Radiotherapy 34 pembrolizumab 26 Radiotherapy, Intensity-Modulated 23 Carboplatin 21 Docetaxel 19 Paclitaxel 18 Fluorouracil 17 Pemetrexed 9 Erlotinib Hydrochloride 9 Nivolumab 8 Gemcitabine 8 Radiation 7 Drug Therapy 7 Bevacizumab 7 durvalumab 6 Panitumumab 6 Everolimus 6 epacadostat 5 Surgical Procedures, Operative 5 Standard of Care 5 Lapatinib 5 Gefitinib 5 Albumin-Bound Paclitaxel 5 130-nm albumin-bound paclitaxel 5 Oxaliplatin 4 Ipilimumab 4 Cyclophosphamide 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡